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Discoidin Domain Receptor 2–microRNA
196a–Mediated Negative Feedback against
Excess Type I Collagen Expression Is Impaired
in Scleroderma Dermal Fibroblasts
Katsunari Makino1, Masatoshi Jinnin1, Jun Aoi1, Ayaka Hirano1, Ikko Kajihara1, Takamitsu Makino1,
Keisuke Sakai1, Satoshi Fukushima1, Yuji Inoue1 and Hironobu Ihn1
Systemic sclerosis (SSc) is characterized by excess collagen deposition in the skin, due to intrinsic transforming
growth factor-b (TGF-b) activation. We tried to determine the expression and the role of discoidin domain
receptor 2 (DDR2) in SSc. The expression of DDR2 mRNA and protein was significantly decreased in SSc dermal
fibroblasts, which was recovered by knocking down TGF-b. The knockdown of DDR2 in normal fibroblasts
induced microRNA-196a expression, which led to type I collagen downregulation, indicating that DDR2 itself
has a negative effect on microRNA-196a expression and inducible effect on collagen expression. In SSc
fibroblasts, however, the DDR2 knockdown did not affect TGF-b signaling and microRNA-196a expression. The
microRNA-196a levels were significantly decreased in normal fibroblasts treated with TGF-b and in SSc
fibroblasts. Taken together our data indicate that, in SSc fibroblasts, intrinsic TGF-b stimulation induces type I
collagen expression, and also downregulates DDR2 expression. This probably acts as a negative feedback
mechanism against excess collagen expression, as a decreased DDR2 expression is supposed to stimulate the
microRNA-196a expression and further change the collagen expression. However, in SSc fibroblasts the
microRNA-196a expression was downregulated by TGF-b signaling. DDR2–microRNA-196a pathway may be a pre-
viously unreported negative feedback system, and its impairment may be involved in the pathogenesis of SSc.
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INTRODUCTION
Systemic sclerosis (SSc) or scleroderma is an acquired disorder
characterized by the activation of fibroblasts and subsequent
excess accumulation of extracellular matrix, resulting in tissue
fibrosis of the skin and internal organs (Korn, 1989; Mauch
and Kreig, 1990). Although the mechanism of fibroblast
activation in SSc is presently unknown, many of the
characteristics of SSc fibroblasts resemble those of healthy
fibroblasts stimulated by transforming growth factor-b1 (TGF-
b1; Leroy et al., 1989; Massague´, 1990): Cultured fibroblasts
obtained from affected SSc skin overproduce various col-
lagens, mainly type I collagen consisting of the a1(I) and a2(I)
chains (LeRoy, 1974; Jimenez et al., 1986; Kikuchi et al.,
1992; Hitraya and Jime´nez, 1996), thus indicating that the
activation of dermal fibroblasts in SSc may be a result of
stimulation by ‘‘autocrine’’ TGF-b signaling. This notion is
supported by our findings that (1) the phosphorylation levels
and DNA-binding activity of Smad3, a downstream mediator
of TGF-b, is constitutively upregulated in SSc fibroblasts
(Asano et al., 2004b), and (2) the blockade of TGF-b signaling
with an anti-TGF-b-neutralizing antibody abolished the
increased expression of human a2(I) collagen mRNA in SSc
fibroblasts (Ihn et al., 2001).
The discoidin domain receptors (DDR1 and DDR2) are
transmembrane receptors belonging to the receptor tyrosine
kinase family (Shrivastava et al., 1997; Vogel et al., 2006).
DDRs consist of three components: an extracellular discoidin
domain, a transmembrane region, and an intracellular kinase
domain (Leitinger, 2003). DDR1 is expressed in epithelial
cells and can bind collagen types I through V and VIII, which
results in autophosphorylation of the receptor, whereas
DDR2 is mainly detected in mesenchymal cells and responds
to collagen types I, II, III, and X (Leitinger and Kwan, 2006;
Ichikawa et al., 2007; Carafoli et al., 2009; Klatt et al., 2009).
Both DDRs are thought to regulate extracellular matrix
remodeling, as well as many cellular activities including cell
proliferation, migration, or adhesion (Wall et al., 2005; Vogel
et al., 2006).
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Although DDRs are known to be receptors of collagens as
described above, the role of DDRs in SSc has not yet been
well investigated. Therefore, this study was undertaken to
clarify the expression pattern of DDRs in SSc and their role in
the pathogenesis of this disease.
RESULTS
Expression levels of DDR2 in SSc skin
As an initial experiment, we compared the transcript levels of
DDR1 and DDR2 between normal and SSc skin in vivo. Total
RNA was extracted from the skin derived from 10 patients
with SSc (5 diffuse cutaneous SSc and 5 limited cutaneous
SSc) and 5 healthy controls, and quantitative real-time PCR
was performed. The relative transcript levels of DDR1 in SSc
skin were not altered compared with normal skin (Figure 1a,
left). On the other hand, the DDR2 expression levels were
significantly lower in SSc skin than those in control skin
(Figure 1a, right).
Next, cultured human dermal fibroblasts obtained from
normal and SSc skin were incubated under the same
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Figure 1. The discoidin domain receptor 2 (DDR2) expression in normal and systemic sclerosis (SSc) skin. (a) The mRNA levels of DDR1 and DDR2 in skin
tissues from five controls, five limited cutaneous SSc (lcSSc) patients, and five diffuse cutaneous SSc (dcSSc) patients. Horizontal lines show means. *Po0.05
compared with values in control skin (1.0). (b) The mRNA levels of DDR1 and DDR2 in normal and SSc-cultured fibroblasts (n¼ 5). (c) Lysates from normal and
SSc-cultured dermal fibroblasts were subjected to immunoblotting with antibody against DDR2 or b-actin. Three representative results for five normal and SSc
fibroblasts are shown. (d) Lysates were obtained from cultured normal and SSc fibroblasts at passages 5, 10, and 15 (p5, p10, and p15), and subjected to
immunoblotting (n¼3). (e, f) Hematoxylin and eosin (HE) and DDR2 staining of (e) normal and SSc skin or (f) mouse skin treated with phosphate-buffered saline
(PBS) or bleomycin (n¼3). DDR2 was stained brown. Arrowheads indicate dermal fibroblasts. Bar¼100 mm.
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conditions, and their mRNA expression was analyzed. The
expression of DDR2 mRNA was also downregulated in SSc
fibroblasts, whereas DDR1 mRNA did not decrease (Figure
1b), which was consistent with the in vivo results (Figure 1a).
Immunoblotting revealed that the amounts of DDR2 protein
in the cell lysates from SSc-cultured fibroblasts were also
decreased compared with those in normal fibroblasts (Figure
1c): The downregulation of DDR2 in SSc cells was maintained
until at least passage 15 in vitro (Figure 1d). Furthermore, the
in vivo DDR2 protein expression in SSc skin was examined by
immunostaining. Hematoxylin and eosin staining showed that
SSc skin has dermal fibrosis with an increased number of
thickened collagen bundles (Figure 1e). The DDR2 expression
was strongly detected in spindle-shaped fibroblasts in normal
skin, but not in SSc fibroblasts in spite of similar staining levels
in the epidermis. Taken together, DDR2 protein and mRNA
expression were significantly downregulated in SSc fibroblasts
both in vivo and in vitro.
To further investigate the DDR2 expression pattern in vivo,
paraffin-embedded sections from the skin of bleomycin-
treated mouse model were stained for DDR2. Weaker DDR2
staining of fibroblasts was found in the bleomycin-induced
thickened skin (Figure 1f) compared with control skin treated
with phosphate-buffered saline. These results confirmed that
DDR2 expression decreased in dermal fibroblasts under
fibrotic conditions.
Regulatory mechanisms for DDR2 in SSc fibroblasts
The steady-state level of mRNA can be affected by the level
of gene transcription and/or the stability of mRNA. To
determine whether the decrease of DDR2 mRNA in SSc
fibroblasts takes place at the transcriptional level or post-
transcriptional level, de novo mRNA synthesis was inhibited
by treatment with actinomycin D, an RNA synthesis inhibitor,
in normal and SSc fibroblasts (Asano et al., 2004a; Mimura
et al., 2005). As shown in Figure 2a, after actinomycin D
treatment, the DDR2 mRNA levels decreased because of
mRNA degradation in both cells. The rate of decrease in the
DDR2 mRNA was similar between normal and SSc fibro-
blasts for at least 12 hours, indicating that the stability of
DDR2 mRNA did not decrease in SSc fibroblasts. Taken
together, DDR2 expression likely decreased because of the
inactivated gene transcription, and not because of the
decreased mRNA stability, in SSc dermal fibroblasts.
We tried to clarify the mechanism that mediates decreased
expression of DDR2 in SSc fibroblasts. To examine the
possibility that the downregulated DDR2 synthesis in SSc
fibroblasts is due to the stimulation of autocrine TGF-b
signaling seen in these cells as described above (Ihn et al.,
2001), we investigated the effect of exogenous TGF-b1
stimulation in normal and SSc fibroblasts. The expression of
DDR2 mRNA was downregulated by TGF-b1 in both normal
(Figure 2b, left) and SSc (Figure 2b, right) fibroblasts. In
addition, immunoblotting revealed that the amount of DDR2
protein was reduced by exogenous TGF-b1 in normal and SSc
fibroblasts (Figure 2c).
In contrast, when the TGF-b1 expression was down-
regulated by TGF-b1 small interfering RNA (siRNA), the a1(I)
and a2(I) collagen expression also decreased in SSc
fibroblasts (Figure 2d), owing to the presence of autocrine
TGF-b signaling (Ihn et al., 2001), but not in normal
fibroblasts. On the other hand, the expression of DDR2 was
not significantly affected by TGF-b siRNA in normal
fibroblasts (Figure 2e, left), although the downregulated
DDR2 protein levels in SSc fibroblasts were recovered by
TGF-b1 siRNA (Figure 2e, right). These results indicate that
the downregulated expression of DDR2 in SSc fibroblasts is a
result of stimulation by autocrine TGF-b signaling.
The function of DDR2 in the regulation of type I collagen in
dermal fibroblasts
As described above, DDR2 is known to be a tyrosine kinase
receptor of collagens. Immunoprecipitation experiments
were performed to evaluate the phosphorylation state of
DDR2 in normal and SSc fibroblasts. Cell lysates were
prepared from normal fibroblasts in the presence or absence
of TGF-b1 and SSc fibroblasts. As shown in Figure 3a, the
DDR2 phosphorylation levels were not different between
normal and SSc fibroblasts. We therefore expected that the
change in expression levels, and not a change in phosphor-
ylation, may have a role in the pathogenesis of SSc.
Accordingly, normal and SSc fibroblasts were transfected
with control or DDR2 siRNA. In normal fibroblasts trans-
fected with DDR2 siRNA, the DDR2 protein expression was
knocked down and type I collagen synthesis was also
downregulated (Figure 3b, left). However, the levels of a2(I)
collagen mRNA in normal fibroblasts did not significantly
decrease by DDR2 siRNA (Figure 3b, right). In SSc fibroblasts,
the protein and mRNA levels of collagen were not
significantly affected by DDR2 siRNA (Figure 3c).
We also overexpressed DDR2 by lentiviral transfection in
normal fibroblasts. As expected, the DDR2 overexpression
induced type I collagen protein expression in a dose-
dependent manner, but the empty vector did not (Figure 3d
and e). Similarly, the expression of type I collagen increased
by DDR2 overexpression in SSc fibroblasts (Figure 3f).
Therefore, the exogenous DDR2 overexpression itself seems
to have an inducible effect on collagen expression.
The association between DDR2 and microRNAs (miRNAs) in
normal and SSc fibroblasts
Finally, to clarify the regulatory mechanism(s) by which DDR2
affects type I collagen expression, we determined whether
DDR2 regulates collagen expression via TGF-b1 signaling. In
normal fibroblasts, Smad2 and Smad3 were not phosphory-
lated (Figure 4a). When DDR2 was knocked down by the
siRNA, total and phosphorylated levels of Smad2/3 were not
affected (Figure 4a). In contrast, although Smad2 and Smad3
were constitutively phosphorylated in SSc fibroblasts (Asano
et al., 2004b), DDR2 siRNA did not alter the phosphorylation
state (Figure 4a). In addition, the mRNA levels of TGF-b1,
TGF-b receptor I, TGF-b receptor II, endoglin, thrombospon-
din 1, integrin b3, or integrin b5 were not influenced by DDR2
siRNA (Figure 4b). In addition, DDR2 overexpression did not
change the levels of phosphorylated Smad2/3 and TGF-b-
related molecules (Figure 4c and d). Next, considering that
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DDR2 regulates collagen protein expression without altering
mRNA levels, we hypothesized that DDR2 regulates type I
collagen expression via miRNAs, because miRNAs usually
inhibit the translation of their target genes and do not cause
degradation of the target transcript. According to the miRNA
target gene predictions using MiRanda (August 2010 Release,
http://www.microrna.org/), TargetScan (version 5.1, http://
www.targetscan.org/), and PicTar (http://pictar.mdc-berlin.
de/), we found several miRNAs, including miR-29, 196a, or
let-7, as putative regulators of a1(I) and a2(I) collagen. DDR2
knockdown by siRNA (Figure 4a) upregulated only the
expression of miR-196a significantly in normal fibroblasts
among these candidates (Figure 4e). In SSc fibroblasts,
however, the miR-196a expression was not affected by
DDR2 siRNA (Figure 4e). In contrast, DDR2 overexpression
(Figure 4c) decreased the miR-196a expression in both normal
and SSc fibroblasts to a similar extent (Figure 4f).
We then confirmed the association of miR-196a with type
I collagen expression in normal and SSc fibroblasts. We used
miRNA mimics and miScript Target Protectors, single-
stranded, modified RNAs designed to specifically interfere
with the interaction between miR-196a and the a1(I)/a2(I)
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Figure 2. Decreased discoidin domain receptor 2 (DDR2) synthesis is induced by stimulation with transforming growth factor-b (TGF-b). (a) Normal and
systemic sclerosis (SSc) fibroblasts were incubated for 3, 9, and 12 hours after treatment with 2.5 mgml1 actinomycin D. DDR2 mRNA expression was analyzed
by real-time PCR and normalized with glyceraldehyde-3-phosphate dehydrogenase (GAPDH; n¼ 3). The values in untreated fibroblasts were set at 100%.
(b, c) Normal and SSc fibroblasts were incubated in the presence or absence of 2 ngml1 TGF-b1 for 24 hours. (b) DDR2 mRNA levels were determined by real-
time PCR (n¼ 5). (c) Protein was analyzed by immunoblotting. (d, e) Normal and SSc fibroblasts were transfected with control or TGF-b1 small interfering RNA
(siRNA) for 96 hours. (d) The mRNA levels of TGF-b1 and collagen were quantified by real-time PCR (n¼5). (e) The expression of DDR2 was analyzed by
immunoblotting. *Po0.05 compared with controls.
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collagen 30-untranslated region (http://www.qiagen.com/pro-
ducts/miscripttargetprotectors.aspx) (Long and Lahiri, 2011).
The transfection of miRNA mimic specific for miR-196a
reduced type I collagen expression, and this effect was
inhibited by the protectors in both normal (Figure 5a) and SSc
(Figure 5b) fibroblasts. These results indicate that miR-196a
can regulate the collagen expression.
We expected that the constitutively downregulated DDR2
in SSc fibroblasts would cause an overexpression of miR-
196a, and that the miR-196a levels would be elevated in SSc
cells compared with normal cells. However, unlike normal
fibroblasts, the expression of miR-196a in SSc fibroblasts was
not upregulated by DDR2 siRNA, as shown above (Figure
4e). Furthermore, miR-196a levels in SSc skin were sig-
nificantly lower than normal skin both in vivo and in vitro
(Figure 5c and d). Therefore, the negative effect of DDR2 on
miR-196a expression may be specific to normal fibroblasts,
and it may be impaired in SSc fibroblasts. The miR-196a
expression was downregulated by exogenous TGF-b1 stimu-
lation in normal fibroblasts (Figure 5e), whereas it was
recovered by TGF-b1 siRNA in SSc fibroblasts (Figure 5f).
Therefore, in SSc fibroblasts, the stimulation of autocrine
TGF-b signaling constitutively downregulates miR-196a,
resulting in the unresponsiveness of miR-196a to DDR2.
DISCUSSION
This study is the first to demonstrate the role of DDR2 in type
I collagen expression in dermal fibroblast and to elucidate its
contribution to the pathogenesis of SSc by three major
findings.
First, we demonstrated a constitutive downregulation of
DDR2 protein and mRNA in cultured SSc fibroblasts in vitro
and in vivo. On the other hand, there was no significant
difference in the DDR1 expression between normal and SSc
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Figure 3. The effect of discoidin domain receptor 2 (DDR2) on the expression of type I collagen. (a) DDR2 was immunoprecipitated and the phosphorylated
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fibroblasts. As described above, DDR1 is expressed in
epithelial cells, whereas DDR2 is mainly found in mesench-
ymal cells including fibroblasts and it has a higher binding
specificity for type I collagen than DDR1 (Leitinger and
Kwan, 2006; Ichikawa et al., 2007; Carafoli et al., 2009; Klatt
et al., 2009). Considering that collagen type I is the most
abundant extracellular matrix protein found in SSc skin
(Mauch and Kreig, 1990), DDR2 may be more important in
the pathogenesis of the disease than DDR1.
Second, as described in the Introduction, numerous
publications have indicated that there is an autocrine
activation of TGF-b signaling in SSc fibroblasts. Our results
suggest that such autocrine TGF-b signaling may play a major
role in the downregulation of DDR2 in SSc dermal
fibroblasts.
Finally, we tried to determine the function of DDR2 in SSc
fibroblasts. We found that the overexpression of DDR2 leads
to type I collagen induction via the downregulation of miR-
196a, whereas the knockdown of DDR2 leads to the
downregulation of collagen expression via the upregulation
of miR-196a in normal fibroblasts, without affecting TGF-b
signaling. Thus, DDR2 may affect the miR-196a expression
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Figure 4. Regulation of microRNA-196a (miR-196a) by discoidin domain receptor 2 (DDR2). (a, b) Fibroblasts were transfected with control or DDR2
small interfering RNA (siRNA). Cell lysates were subjected to immunoblotting. (a) A representative result from five independent experiments is shown.
(b) The mRNA levels of transforming growth factor-b1 (TGF-b1), TGF-b receptor I (TGFBR1), TGF-b receptor II (TGFBR2), endoglin (ENG), thrombospondin-1
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directly, not via TGF-b signaling. The miRNAs, which are
short ribonucleic acid molecules only 22 nucleotides long on
average, bind to the 30-untranslated regions of target mRNAs
and lead to gene silencing. Recent vigorous research efforts in
this field indicated that miRNAs play a role in the pathogen-
esis of numerous disorders (Chen and Gorski, 2008;
Kuehbacher et al., 2008; Lu and Liston, 2009; Davidson-
Moncada et al., 2010; Furer et al., 2010). Our study suggests
that miRNAs are also involved in the regulatory mechanisms
of extracellular matrix protein and tissue fibrosis.
Thus, DDR2 itself has an inducible effect on collagen
expression in normal fibroblasts. In SSc fibroblasts, autocrine
TGF-b stimulation induces type I collagen expression, and
also downregulates DDR2 expression. This probably acts
as a negative feedback mechanism against excess collagen
expression, as a decreased DDR2 expression is supposed to
stimulate the miR-196a expression and further change the
collagen expression. However, in SSc fibroblasts the miR-
196a expression was downregulated by TGF-b signaling,
which releases collagen expression and promotes tissue
fibrosis. Thus, our data showed that the DDR2–miR-
196a–mediated negative feedback mechanism was impaired
in SSc fibroblasts: the constitutive downregulation of down-
stream miR-196a by TGF-b signaling causes an unrespon-
siveness of miR-196a to the upstream DDR2 (Figure 6).
Multiple negative feedback systems for TGF-b signaling have
been shown to be impaired in SSc fibroblasts (Asano et al.,
2004b; Jinnin et al., 2007). For example, c-Ski/SnoN is
induced by exogenous TGF-b stimulation, which attenuates
the effect of TGF-b on collagen expression in normal
fibroblasts. However, in SSc fibroblasts, forced overexpres-
sion of c-Ski/SnoN does not affect the excess collagen
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transfected with control or miR-196a mimic in the presence or absence of miScript Target protector for 96 hours. Lysates were subjected to immunoblotting.
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(e) Normal fibroblasts were stimulated with 2 ngml1 transforming growth factor-b1 (TGF-b1) for 24 hours. Relative miR-196a expressions were determined
by real-time PCR (n¼ 4). (f) SSc fibroblasts were transfected with control small interfering RNA (siRNA) or TGF-b1 siRNA for 96 hours. Then, relative
miR-196a levels were determined by PCR (n¼4). *Po0.05 compared with controls.
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expression (Jinnin et al., 2007). The DDR2–miR-196a path-
way may be a new negative feedback system that protects
against TGF-b-mediated excess collagen accumulation, and
its impairment may be involved in the pathogenesis of SSc.
Further studies are needed to confirm the direct interaction
between miR-196a and collagen using a 30-untranslated
region reporter assay.
In summary, we demonstrated that an impairment of the
DDR2–miRNA–mediated regulation of type I collagen in SSc
fibroblasts may play an important role in the maintenance of
fibrosis. Investigations of the overall regulatory mechanisms
of fibrosis by DDR2 and miRNAs may lead to new
therapeutic approaches for this disease.
MATERIALS AND METHODS
Reagents
The antibodies against DDR2 and type I collagen were purchased
from R&D Systems (Minneapolis, MN) and Southern Biotechnologies
(Birmingham, AL), respectively. The antibodies against b-actin,
Smad2/3, and phosphorylated Smad2/3 were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). Antibodies for Smad2/3 and
phosphorylated Smad2 were from Cell Signaling (Danvers, MA). The
anti-phosphotyrosine antibody 4G10 and EGF-stimulated A431 cell
lysates were from Upstate Biotechnology (Lake Placid, NY).
Recombinant human TGF-b1 was obtained from R&D Systems.
Actinomycin D was purchased from Sigma (St Louis, MO).
Patient materials
Skin samples were obtained from five diffuse cutaneous SSc patients
and five limited cutaneous SSc patients (LeRoy et al., 1988). Control
skin samples were obtained from routinely discarded skin of healthy
human subjects undergoing skin grafting. Immediately after removal,
skin samples were fixed in formalin and embedded in paraffin (Ihn
et al., 1996). Institutional review board approval and written
informed consent were obtained before patients and healthy
volunteers were entered into this study, according to the Declaration
of Helsinki Principles.
Cell culture
Human dermal fibroblasts were obtained by skin biopsies from
the affected areas (dorsal forearm) of 5 diffuse cutaneous SSc
patients who had o2 years of skin thickening (Ihn et al., 1997).
Control fibroblasts were obtained by skin biopsies from 5 healthy
donors. Institutional review board approval and written informed
consent were obtained according to the Declaration of Helsinki
Principles.
Analysis of RNA and miRNA
Total RNA from formalin-fixed, paraffin-embedded tissue sections
was extracted with RNeasy FFPE Kit (QIAGEN, Hilden, Germany).
Total RNA from cultured cells was extracted using ISOGEN (Nippon
Gene, Tokyo, Japan). First-strand complementary DNA was synthe-
sized by the PrimeScript RT reagent Kit (Takara, Otsu, Japan).
Quantitative real-time PCR used primers and templates mixed with
the SYBR Premix Ex Taq II Kit (Takara). Primer sets for DDR1
(PPH19940E, designed against exon 16), DDR2 (PPH20974A,
designed against exon 19), TGF-b1 (PPH00508A, against exon 2),
and glyceraldehyde-3-phosphate dehydrogenase (PPH00150E,
against exon 9) were purchased from SABiosciences (Frederick,
MD). Primer sets for a1(I) collagen (sense 50-CCCGGGTTTCAGA
GACAACTTC-30, antisense 50-TCCACATGCTTTATTCCAGCAATC-
30), a2(I) collagen (sense 50-GAGGGCAACAGCAGGTTCACTTA-30,
antisense 50-TCAGCACCACCGATGTCCA-30), TGF-b receptor I
(sense 50-AACCCTGCCTAGTGCAAGTTACAA-30, antisense 50-GAC
TAACAAATGTGCTGACCCAAAG-30), TGF-b receptor II (sense 50-
AACCCTGCCTAGTGCAAGTTACAA-30, antisense 50-GACTAAC
AAATGTGCTGACCCAAAG-30), endoglin (sense 50-TTGAACAT
CATCAGCCCTGACC-30, antisense 50-CGTGTGCGAGTAGATGTAC
CAGAG-30), thrombospondin 1 (sense 50-GGAGACAAAGACTG
GCTTCTGGAC-30, antisense 50-GGCCACTGCAGGTGATGAGTA
A-30), integrin b3 (sense 50-ACTGTGTCATCAAATGTGCGGTTA-30,
antisense 50-GCTCTTGCCAAAGCCAGGTC-30), and integrin b5
(sense 50-GTTTCAGAGCGAGCGATCCAG-30, antisense 50-CACAG
TGCCATTGTAGGATTTGTTG-30) were from Takara. DNA was
amplified for 40 cycles of denaturation for 5 seconds at 95 1C and
annealing for 30 seconds at 60 1C. The transcript levels were
normalized to those of glyceraldehyde-3-phosphate dehydrogenase.
The miRNA isolation from total RNA was performed using RT2
qPCR-Grade miRNA Isolation Kit (SABioscience). For quantitative
real-time PCR, primers for miR-196a or U6 (SABioscience) and
templates were mixed with the RT2 Real-Time PCR master mix
(SABiosciences). DNA was amplified for 40 cycles of denaturation
for 5 seconds at 95 1C and annealing for 30 seconds at 60 1C. The
transcript levels of miR-196a were normalized to those of U6.
Cell lysis and immunoblotting
Fibroblasts were lysed in Denaturing Cell Extraction Buffer
(BIOSOURCE, Camarillo, CA). Aliquots of the cell lysates (normal-
ized for protein concentrations) were subjected to electrophoresis on
SDS-polyacrylamide gels and transferred onto polyvinylidene
difluoride filters. These filters were then incubated with primary
antibodies.
Type I
collagen
Tissue
fibrosis
Type I
collagen
Autocrine
TGF-β1
miR-196a
miR-196a
DDR2 DDR2
DDR2
SSc fibroblastNormal fibroblast
Figure 6. A hypothetical model of the role of discoidin domain receptor 2
(DDR2) in systemic sclerosis (SSc) fibroblasts. DDR2 has a negative effect on
microRNA-196a (miR-196a) expression and an inducible effect on collagen
expression in normal fibroblasts. In SSc fibroblasts, autocrine transforming
growth factor-b (TGF-b) stimulation induces collagen expression, and also
downregulates DDR2 expression as a negative feedback mechanism to
protect against excess collagen expression. However, the DDR2–miR-
196a–mediated negative feedback is impaired: the constitutive
downregulation of miR-196a by TGF-b causes an unresponsiveness of the
miRNA to DDR2, leading to tissue fibrosis.
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Immunoprecipitation
Cell lysates were prepared from normal fibroblasts in the presence or
absence of TGF-b1 (2 ngml1) for 24 hours and SSc fibroblasts on
15 cm dishes. Cells were lysed in Pierce IP lysis buffer (Thermo,
Rockford, IL) with the Halt phosphatase inhibitor cocktail (Thermo).
The lysates were precleared with 20ml of Protein A/G Plus Agarose
(Santa Cruz) at 4 1C for 1 hour. For DDR2 immunoprecipitation, the
lysates were incubated with an anti-DDR2 antibody (2 mg) and 40 ml
of Protein A/G Plus Agarose overnight at 4 1C. The immunopreci-
pitated proteins were washed 5 times with Pierce buffer. Agarose-
bound proteins were extracted by a 5-minute incubation in sample
buffer at 95 1C. The sample was then assessed by immunoblotting.
Phosphorylated DDR2 was detected using 4G10. The same
membrane was stripped and reprobed with anti-DDR2 antibody.
EGF-stimulated A431 cell lysates were used as positive control (Gill
and Lazar, 1981).
Immunohistochemistry
Wax-embedded sections (4mm thick) were dewaxed in xylene and
rehydrated in graded alcohols. Antigens were retrieved by incuba-
tion with an antigen retrieval solution (pH 9; Nichirei, Tokyo, Japan)
for 10minutes with an autoclave apparatus at 121 1C. The
endogenous peroxidase activity was inhibited, after which the
sections were blocked with 10% rabbit blood serum for 20minutes
and then reacted with the antibody against DDR2 (15 mgml1)
overnight at 4 1C. After the excess antibody was washed off with
phosphate-buffered saline, sections were incubated with horseradish
peroxidase–labeled rabbit anti-goat antibody (Nichirei) for 60min-
utes at 20 1C. The reaction was visualized by the diaminobenzidine
substrate system (Dojin, Kumamoto, Japan). Slides were counter-
stained with Mayer’s hematoxylin.
Intradermal treatment with bleomycin
Bleomycin (Nippon Kayaku, Tokyo, Japan) was dissolved in
phosphate-buffered saline at a concentration of 1mgml1 and
sterilized by filtration (Yamamoto et al., 1999; Tanaka et al., 2010).
Bleomycin or phosphate-buffered saline (100ml) was injected
intradermally into the shaved backs of 6-week-old C57BL/6
mice (CLEA, Tokyo, Japan) daily for 4 weeks. The back skin samples
were removed on the day after the final injection, fixed in
10% formalin solution, and embedded in paraffin. This protocol
was approved by the Committee on the Animal Research at
Kumamoto University.
Transient transfection
The siRNA against TGF-b1 (sc-37191; mixture of three siRNA
duplexes: GACACCAACUAUUGCUUCAtt, CUGUCUGCACUAU
UCCUUUtt, and GAACACUACUGUAGUUAGAtt) or DDR2
(sc-39922, mixture of three siRNA duplexes: GUAUGAGAGUG
GAGCUUUAtt, CAUCCAGGCUGAUACGAAAtt, and CACUCCAU
CUGGACAUUUAtt) was purchased from Santa Cruz Biotechnology.
The miRNA mimics and miScript target protectors were purchased
from QIAGEN. For reverse transfection, siRNA, miRNA mimics, or
miScript target protectors mixed with Lipofectamine RNAiMAX
(Invitrogen, Carlsbad, CA) were added when 3 104 cells per well
were plated in 24-well culture dishes, followed by incubation for
24–96hours at 37 1C in 5% CO2. Control experiments showed a
480% transfection efficiency (data not shown).
Lentiviral gene transfer
The constructs containing full-length human DDR2 complementary
DNA were provided by Libo Yao (Fourth Military Medical
University, China) (Su et al., 2009). CSII-EF-RfA, pCMV-VSV-G-
RSV-Rev, and pHIVgp, necessary for lentiviral gene expression, were
kindly donated by Hiroyuki Miyoshi (RIKEN, Wako, Japan). The
DDR2 complementary DNAs were cloned into CSII-EF-RfA (Tahara-
Hanaoka et al., 2002). A lentiviral vector–mediated gene transfer was
performed as described (Tahara-Hanaoka et al., 2002).
Statistical analysis
The data were expressed as the means±SD of at least three
independent experiments. The statistical analysis was carried out
using Mann–Whitney U test. The P-values ofo0.05 were considered
to be significant.
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